| Financial Year |
March 31 2023 |
| Monetary Funds |
449,764,302.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,482,827.60 |
| Accounts Receivable |
193,920,178.09 |
| Advances to Suppliers |
8,377,583.49 |
| Other Receivables |
2,976,298.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
146,513,217.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,813,554.26 |
| Total Current Assets |
822,630,618.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
175,766,843.70 |
| Under-construction Projects |
7,552,166.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,576,705.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,964,419.84 |
| Deferred Income Tax Assets |
7,812,099.61 |
| Other Non-Current Assets |
7,231,159.44 |
| Sub-Total of Non-Current Assets |
236,830,990.64 |
| Total Assets |
1,059,461,608.71 |
| Short-Term Loans |
30,298,083.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,556,480.51 |
| Accounts Payable |
173,347,354.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,735,866.24 |
| Taxes Payable |
15,414,889.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,341,506.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,671,712.44 |
| Other Current Liabilities |
6,955,076.42 |
| Sub-Total of Current Liabilities |
309,821,557.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
511,420.00 |
| Deferred Income Tax Liabilities |
1,025,632.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,105,290.94 |
| Total Liabilities |
315,926,848.56 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
113,899,773.18 |
| Surplus Reserve |
52,474,707.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
377,134,279.36 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
743,534,760.15 |
| Owner's Equity（Stockholder's Equity） |
743,534,760.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,059,461,608.71 |
